MedTech OITBs join forces in the fight against COVID-19
The novel corona virus causing COVID-19 overwhelmed Europe and the world in just a few weeks’ time. Especially Small and Medium-sized Enterprises (SMEs) are put at very high risk by the slowdown or shutdown of economic life in their countries – exactly those companies who ensure the development of innovative solutions urgently required for counteracting the impacts of COVID-19 and for helping to control possible future outbreaks alike.
Consequently, in this case of emergency the three MedTech Open Innovation Testbed (OITB) projects TBMED, MDOT and SAFE-N-MEDTEC decided to work together and open a call to include new case studies in their on-going projects. Innovative SMEs working on the development of solutions to fight the virus will be able to apply to this call. The three projects have allocated part of their budgets in order to provide services to selected SMEs and help them reach the market faster.
The concept of OITBs to forge pan-European innovation networks tailored to the specific needs of SMEs makes them the ideal instruments for quickly finding solutions under urgent conditions such as the COVID-19 outbreak.
The three OITBs thus initiate a call for expressions of interest from MedTech SMEs performing COVID-19-related developments. Support will be provided in the following ways:
- TBMED offers services to SMEs from the high-risk medical devices sector, particularly with regard to characterization, prevention, diagnosis, treatment, follow-up and the forecast of patient prognosis related to COVID-19. Such services include, among others, early dialogues with the Basque HTA office, expert advice for regional and/or multinational clinical trials on COVID-19 and the assessment of needs of such companies regarding clinical trials.
- MDOT members who develop routines and processes to accelerate the conformity assessment of medical devices, offer consultation regarding regulatory affairs and technology development in the fields of inhalation technologies and environmental sensors.
- SAFE-N-MEDTECH with its key expertise in nano-enabled medical technologies, offers characterization, preclinical validation, access to biobanks and patient samples, scale up and regulatory support, technology assessment and horizon scanning.
Expressions of interest from SMEs will be accepted starting September 15, 2020.
Stay tuned! More information will follow soon.